APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biothrax (Anthrax Vaccine)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biothrax (Anthrax Vaccine) Market Analysis and Forecast 2026-2032

2 January 2026219 pages

Choose your research edition.

Industry ResearchBiothrax (Anthrax Vaccine) Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Biothrax (Anthrax Vaccine) Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Biothrax (Anthrax Vaccine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biothrax (Anthrax Vaccine) Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Biothrax (Anthrax Vaccine) Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Biothrax (Anthrax Vaccine) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biothrax (Anthrax Vaccine) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biothrax (Anthrax Vaccine) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biothrax (Anthrax Vaccine) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biothrax (Anthrax Vaccine) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Biothrax (Anthrax Vaccine) include Merck, Tiankang, Zoetis, Vecol, Rosenbusch, Prondil, PharmAthene, Merial and JOVAC, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Biothrax (Anthrax Vaccine), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biothrax (Anthrax Vaccine), also provides the sales of main regions and countries. Of the upcoming market potential for Biothrax (Anthrax Vaccine), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biothrax (Anthrax Vaccine) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biothrax (Anthrax Vaccine) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Biothrax (Anthrax Vaccine) sales, projected growth trends, production technology, application and end-user industry.

Biothrax (Anthrax Vaccine) Segment by Company

Merck

Tiankang

Zoetis

Vecol

Rosenbusch

Prondil

PharmAthene

Merial

JOVAC

IVPM

Intervac

Indian Immunologicals

CVCRI

Colorado Serum

Ceva Santé Animale

CDV

CAVAC

Botswana Vaccine Institute

Biogénesis-Bago

Bayer Sanidad Animal

Agrovet

Biothrax (Anthrax Vaccine) Segment by Type

Live Vaccines

Cell Free PA Vaccines

Biothrax (Anthrax Vaccine) Segment by Application

Human Use

Animal Use

Biothrax (Anthrax Vaccine) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biothrax (Anthrax Vaccine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biothrax (Anthrax Vaccine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biothrax (Anthrax Vaccine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Biothrax (Anthrax Vaccine) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Biothrax (Anthrax Vaccine) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biothrax (Anthrax Vaccine) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biothrax (Anthrax Vaccine) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Live Vaccines Major Manufacturers Table 3. Cell Free PA Vaccines Major Manufacturers Table 4. Global Biothrax (Anthrax Vaccine) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Human Use Major Manufacturers Table 6. Animal Use Major Manufacturers Table 7. Biothrax (Anthrax Vaccine) Industry Trends Table 8. Biothrax (Anthrax Vaccine) Industry Drivers Table 9. Biothrax (Anthrax Vaccine) Industry Opportunities and Challenges Table 10. Biothrax (Anthrax Vaccine) Industry Restraints Table 11. Global Biothrax (Anthrax Vaccine) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Biothrax (Anthrax Vaccine) Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Biothrax (Anthrax Vaccine) Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2021-2026) Table 15. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2027-2032) Table 16. Global Biothrax (Anthrax Vaccine) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Biothrax (Anthrax Vaccine) Sales by Region (2021-2026) & (K Units) Table 18. Global Biothrax (Anthrax Vaccine) Sales by Region (2027-2032) & (K Units) Table 19. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2021-2026) Table 20. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2027-2032) Table 21. Global Biothrax (Anthrax Vaccine) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Biothrax (Anthrax Vaccine) Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2021-2026) Table 25. Global Biothrax (Anthrax Vaccine) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Biothrax (Anthrax Vaccine) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Biothrax (Anthrax Vaccine) Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Biothrax (Anthrax Vaccine) Manufacturers, Product Type & Application Table 29. Global Biothrax (Anthrax Vaccine) Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Biothrax (Anthrax Vaccine) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Biothrax (Anthrax Vaccine) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Biothrax (Anthrax Vaccine) Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Biothrax (Anthrax Vaccine) Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2021-2026) Table 36. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2027-2032) Table 37. Global Biothrax (Anthrax Vaccine) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units) Table 39. Global Biothrax (Anthrax Vaccine) Sales by Type (2027-2032) & (K Units) Table 40. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2021-2026) Table 41. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2027-2032) Table 42. Global Biothrax (Anthrax Vaccine) Price by Type (2021-2026) & (US$/Unit) Table 43. Global Biothrax (Anthrax Vaccine) Price by Type (2027-2032) & (US$/Unit) Table 44. Global Biothrax (Anthrax Vaccine) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Biothrax (Anthrax Vaccine) Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Biothrax (Anthrax Vaccine) Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2021-2026) Table 48. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2027-2032) Table 49. Global Biothrax (Anthrax Vaccine) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units) Table 51. Global Biothrax (Anthrax Vaccine) Sales by Application (2027-2032) & (K Units) Table 52. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2021-2026) Table 53. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2027-2032) Table 54. Global Biothrax (Anthrax Vaccine) Price by Application (2021-2026) & (US$/Unit) Table 55. Global Biothrax (Anthrax Vaccine) Price by Application (2027-2032) & (US$/Unit) Table 56. Merck Company Information Table 57. Merck Business Overview Table 58. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Merck Biothrax (Anthrax Vaccine) Product Portfolio Table 60. Merck Recent Development Table 61. Tiankang Company Information Table 62. Tiankang Business Overview Table 63. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Tiankang Biothrax (Anthrax Vaccine) Product Portfolio Table 65. Tiankang Recent Development Table 66. Zoetis Company Information Table 67. Zoetis Business Overview Table 68. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Zoetis Biothrax (Anthrax Vaccine) Product Portfolio Table 70. Zoetis Recent Development Table 71. Vecol Company Information Table 72. Vecol Business Overview Table 73. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Vecol Biothrax (Anthrax Vaccine) Product Portfolio Table 75. Vecol Recent Development Table 76. Rosenbusch Company Information Table 77. Rosenbusch Business Overview Table 78. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolio Table 80. Rosenbusch Recent Development Table 81. Prondil Company Information Table 82. Prondil Business Overview Table 83. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Prondil Biothrax (Anthrax Vaccine) Product Portfolio Table 85. Prondil Recent Development Table 86. PharmAthene Company Information Table 87. PharmAthene Business Overview Table 88. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. PharmAthene Biothrax (Anthrax Vaccine) Product Portfolio Table 90. PharmAthene Recent Development Table 91. Merial Company Information Table 92. Merial Business Overview Table 93. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Merial Biothrax (Anthrax Vaccine) Product Portfolio Table 95. Merial Recent Development Table 96. JOVAC Company Information Table 97. JOVAC Business Overview Table 98. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. JOVAC Biothrax (Anthrax Vaccine) Product Portfolio Table 100. JOVAC Recent Development Table 101. IVPM Company Information Table 102. IVPM Business Overview Table 103. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. IVPM Biothrax (Anthrax Vaccine) Product Portfolio Table 105. IVPM Recent Development Table 106. Intervac Company Information Table 107. Intervac Business Overview Table 108. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Intervac Biothrax (Anthrax Vaccine) Product Portfolio Table 110. Intervac Recent Development Table 111. Indian Immunologicals Company Information Table 112. Indian Immunologicals Business Overview Table 113. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolio Table 115. Indian Immunologicals Recent Development Table 116. CVCRI Company Information Table 117. CVCRI Business Overview Table 118. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. CVCRI Biothrax (Anthrax Vaccine) Product Portfolio Table 120. CVCRI Recent Development Table 121. Colorado Serum Company Information Table 122. Colorado Serum Business Overview Table 123. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolio Table 125. Colorado Serum Recent Development Table 126. Ceva Santé Animale Company Information Table 127. Ceva Santé Animale Business Overview Table 128. Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Portfolio Table 130. Ceva Santé Animale Recent Development Table 131. CDV Company Information Table 132. CDV Business Overview Table 133. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. CDV Biothrax (Anthrax Vaccine) Product Portfolio Table 135. CDV Recent Development Table 136. CAVAC Company Information Table 137. CAVAC Business Overview Table 138. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. CAVAC Biothrax (Anthrax Vaccine) Product Portfolio Table 140. CAVAC Recent Development Table 141. Botswana Vaccine Institute Company Information Table 142. Botswana Vaccine Institute Business Overview Table 143. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolio Table 145. Botswana Vaccine Institute Recent Development Table 146. Biogénesis-Bago Company Information Table 147. Biogénesis-Bago Business Overview Table 148. Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Portfolio Table 150. Biogénesis-Bago Recent Development Table 151. Bayer Sanidad Animal Company Information Table 152. Bayer Sanidad Animal Business Overview Table 153. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolio Table 155. Bayer Sanidad Animal Recent Development Table 156. Agrovet Company Information Table 157. Agrovet Business Overview Table 158. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Agrovet Biothrax (Anthrax Vaccine) Product Portfolio Table 160. Agrovet Recent Development Table 161. North America Biothrax (Anthrax Vaccine) Revenue by Type (2021-2026) & (US$ Million) Table 162. North America Biothrax (Anthrax Vaccine) Revenue by Type (2027-2032) & (US$ Million) Table 163. North America Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units) Table 164. North America Biothrax (Anthrax Vaccine) Sales by Type (2027-2032) & (K Units) Table 165. North America Biothrax (Anthrax Vaccine) Sales Price by Type (2021-2026) & (US$/Unit) Table 166. North America Biothrax (Anthrax Vaccine) Sales Price by Type (2027-2032) & (US$/Unit) Table 167. North America Biothrax (Anthrax Vaccine) Revenue by Application (2021-2026) & (US$ Million) Table 168. North America Biothrax (Anthrax Vaccine) Revenue by Application (2027-2032) & (US$ Million) Table 169. North America Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units) Table 170. North America Biothrax (Anthrax Vaccine) Sales by Application (2027-2032) & (K Units) Table 171. North America Biothrax (Anthrax Vaccine) Sales Price by Application (2021-2026) & (US$/Unit) Table 172. North America Biothrax (Anthrax Vaccine) Sales Price by Application (2027-2032) & (US$/Unit) Table 173. North America Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. North America Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. North America Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. North America Biothrax (Anthrax Vaccine) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 177. North America Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 178. North America Biothrax (Anthrax Vaccine) Sales by Country (2027-2032) & (K Units) Table 179. North America Biothrax (Anthrax Vaccine) Sales Price by Country (2021-2026) & (US$/Unit) Table 180. North America Biothrax (Anthrax Vaccine) Sales Price by Country (2027-2032) & (US$/Unit) Table 181. United States Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 182. Canada Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 183. Europe Biothrax (Anthrax Vaccine) Revenue by Type (2021-2026) & (US$ Million) Table 184. Europe Biothrax (Anthrax Vaccine) Revenue by Type (2027-2032) & (US$ Million) Table 185. Europe Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units) Table 186. Europe Biothrax (Anthrax Vaccine) Sales by Type (2027-2032) & (K Units) Table 187. Europe Biothrax (Anthrax Vaccine) Sales Price by Type (2021-2026) & (US$/Unit) Table 188. Europe Biothrax (Anthrax Vaccine) Sales Price by Type (2027-2032) & (US$/Unit) Table 189. Europe Biothrax (Anthrax Vaccine) Revenue by Application (2021-2026) & (US$ Million) Table 190. Europe Biothrax (Anthrax Vaccine) Revenue by Application (2027-2032) & (US$ Million) Table 191. Europe Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units) Table 192. Europe Biothrax (Anthrax Vaccine) Sales by Application (2027-2032) & (K Units) Table 193. Europe Biothrax (Anthrax Vaccine) Sales Price by Application (2021-2026) & (US$/Unit) Table 194. Europe Biothrax (Anthrax Vaccine) Sales Price by Application (2027-2032) & (US$/Unit) Table 195. Europe Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Europe Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Europe Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Europe Biothrax (Anthrax Vaccine) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 199. Europe Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 200. Europe Biothrax (Anthrax Vaccine) Sales by Country (2027-2032) & (K Units) Table 201. Europe Biothrax (Anthrax Vaccine) Sales Price by Country (2021-2026) & (US$/Unit) Table 202. Europe Biothrax (Anthrax Vaccine) Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Germany Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 204. France Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 205. U.K. Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 206. Italy Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 207. Netherlands Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 208. China Biothrax (Anthrax Vaccine) Revenue by Type (2021-2026) & (US$ Million) Table 209. China Biothrax (Anthrax Vaccine) Revenue by Type (2027-2032) & (US$ Million) Table 210. China Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units) Table 211. China Biothrax (Anthrax Vaccine) Sales by Type (2027-2032) & (K Units) Table 212. China Biothrax (Anthrax Vaccine) Sales Price by Type (2021-2026) & (US$/Unit) Table 213. China Biothrax (Anthrax Vaccine) Sales Price by Type (2027-2032) & (US$/Unit) Table 214. China Biothrax (Anthrax Vaccine) Revenue by Application (2021-2026) & (US$ Million) Table 215. China Biothrax (Anthrax Vaccine) Revenue by Application (2027-2032) & (US$ Million) Table 216. China Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units) Table 217. China Biothrax (Anthrax Vaccine) Sales by Application (2027-2032) & (K Units) Table 218. China Biothrax (Anthrax Vaccine) Sales Price by Application (2021-2026) & (US$/Unit) Table 219. China Biothrax (Anthrax Vaccine) Sales Price by Application (2027-2032) & (US$/Unit) Table 220. Asia Biothrax (Anthrax Vaccine) Revenue by Type (2021-2026) & (US$ Million) Table 221. Asia Biothrax (Anthrax Vaccine) Revenue by Type (2027-2032) & (US$ Million) Table 222. Asia Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units) Table 223. Asia Biothrax (Anthrax Vaccine) Sales by Type (2027-2032) & (K Units) Table 224. Asia Biothrax (Anthrax Vaccine) Sales Price by Type (2021-2026) & (US$/Unit) Table 225. Asia Biothrax (Anthrax Vaccine) Sales Price by Type (2027-2032) & (US$/Unit) Table 226. Asia Biothrax (Anthrax Vaccine) Revenue by Application (2021-2026) & (US$ Million) Table 227. Asia Biothrax (Anthrax Vaccine) Revenue by Application (2027-2032) & (US$ Million) Table 228. Asia Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units) Table 229. Asia Biothrax (Anthrax Vaccine) Sales by Application (2027-2032) & (K Units) Table 230. Asia Biothrax (Anthrax Vaccine) Sales Price by Application (2021-2026) & (US$/Unit) Table 231. Asia Biothrax (Anthrax Vaccine) Sales Price by Application (2027-2032) & (US$/Unit) Table 232. Asia Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 233. Asia Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 234. Asia Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 235. Asia Biothrax (Anthrax Vaccine) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 236. Asia Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 237. Asia Biothrax (Anthrax Vaccine) Sales by Country (2027-2032) & (K Units) Table 238. Asia Biothrax (Anthrax Vaccine) Sales Price by Country (2021-2026) & (US$/Unit) Table 239. Asia Biothrax (Anthrax Vaccine) Sales Price by Country (2027-2032) & (US$/Unit) Table 240. Japan Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 241. South Korea Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 242. India Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 243. Australia Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 244. China Taiwan Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 245. Southeast Asia Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 246. SAMEA Biothrax (Anthrax Vaccine) Revenue by Type (2021-2026) & (US$ Million) Table 247. SAMEA Biothrax (Anthrax Vaccine) Revenue by Type (2027-2032) & (US$ Million) Table 248. SAMEA Biothrax (Anthrax Vaccine) Sales by Type (2021-2026) & (K Units) Table 249. SAMEA Biothrax (Anthrax Vaccine) Sales by Type (2027-2032) & (K Units) Table 250. SAMEA Biothrax (Anthrax Vaccine) Sales Price by Type (2021-2026) & (US$/Unit) Table 251. SAMEA Biothrax (Anthrax Vaccine) Sales Price by Type (2027-2032) & (US$/Unit) Table 252. SAMEA Biothrax (Anthrax Vaccine) Revenue by Application (2021-2026) & (US$ Million) Table 253. SAMEA Biothrax (Anthrax Vaccine) Revenue by Application (2027-2032) & (US$ Million) Table 254. SAMEA Biothrax (Anthrax Vaccine) Sales by Application (2021-2026) & (K Units) Table 255. SAMEA Biothrax (Anthrax Vaccine) Sales by Application (2027-2032) & (K Units) Table 256. SAMEA Biothrax (Anthrax Vaccine) Sales Price by Application (2021-2026) & (US$/Unit) Table 257. SAMEA Biothrax (Anthrax Vaccine) Sales Price by Application (2027-2032) & (US$/Unit) Table 258. SAMEA Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 259. SAMEA Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 260. SAMEA Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 261. SAMEA Biothrax (Anthrax Vaccine) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 262. SAMEA Biothrax (Anthrax Vaccine) Sales by Country (2021-2026) & (K Units) Table 263. SAMEA Biothrax (Anthrax Vaccine) Sales by Country (2027-2032) & (K Units) Table 264. SAMEA Biothrax (Anthrax Vaccine) Sales Price by Country (2021-2026) & (US$/Unit) Table 265. SAMEA Biothrax (Anthrax Vaccine) Sales Price by Country (2027-2032) & (US$/Unit) Table 266. Brazil Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 267. Argentina Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 268. Chile Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 269. Colombia Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 270. Peru Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 271. Saudi Arabia Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 272. Israel Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 273. UAE Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 274. Turkey Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 275. Iran Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 276. Egypt Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Table 277. Key Raw Materials Table 278. Raw Materials Key Suppliers Table 279. Biothrax (Anthrax Vaccine) Distributors List Table 280. Biothrax (Anthrax Vaccine) Customers List Table 281. Research Programs/Design for This Report Table 282. Authors List of This Report Table 283. Secondary Sources Table 284. Primary Sources List of Figures Figure 1. Biothrax (Anthrax Vaccine) Image Figure 2. Global Biothrax (Anthrax Vaccine) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biothrax (Anthrax Vaccine) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Live Vaccines Image Figure 5. Cell Free PA Vaccines Image Figure 6. Global Biothrax (Anthrax Vaccine) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Biothrax (Anthrax Vaccine) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Human Use Image Figure 9. Animal Use Image Figure 10. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Biothrax (Anthrax Vaccine) Revenue (2021-2032) & (US$ Million) Figure 12. Global Biothrax (Anthrax Vaccine) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2021-2032) Figure 15. Global Biothrax (Anthrax Vaccine) Sales (2021-2032) & (K Units) Figure 16. Global Biothrax (Anthrax Vaccine) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Biothrax (Anthrax Vaccine) Sales YoY (2021-2032) & (K Units) Figure 19. Europe Biothrax (Anthrax Vaccine) Sales YoY (2021-2032) & (K Units) Figure 20. China Biothrax (Anthrax Vaccine) Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Biothrax (Anthrax Vaccine) Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Biothrax (Anthrax Vaccine) Sales YoY (2021-2032) & (K Units) Figure 23. Global Biothrax (Anthrax Vaccine) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Biothrax (Anthrax Vaccine) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Biothrax (Anthrax Vaccine) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2021-2032) Figure 29. Global Biothrax (Anthrax Vaccine) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2021-2032) Figure 32. Global Biothrax (Anthrax Vaccine) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2021-2032) Figure 35. Global Biothrax (Anthrax Vaccine) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2021-2032) Figure 38. North America Biothrax (Anthrax Vaccine) Revenue Share by Type (2021-2032) Figure 39. North America Biothrax (Anthrax Vaccine) Sales Share by Type (2021-2032) Figure 40. North America Biothrax (Anthrax Vaccine) Revenue Share by Application (2021-2032) Figure 41. North America Biothrax (Anthrax Vaccine) Sales Share by Application (2021-2032) Figure 42. North America Biothrax (Anthrax Vaccine) Revenue Share by Country (2021-2032) Figure 43. North America Biothrax (Anthrax Vaccine) Sales Share by Country (2021-2032) Figure 44. Europe Biothrax (Anthrax Vaccine) Revenue Share by Type (2021-2032) Figure 45. Europe Biothrax (Anthrax Vaccine) Sales Share by Type (2021-2032) Figure 46. Europe Biothrax (Anthrax Vaccine) Revenue Share by Application (2021-2032) Figure 47. Europe Biothrax (Anthrax Vaccine) Sales Share by Application (2021-2032) Figure 48. Europe Biothrax (Anthrax Vaccine) Revenue Share by Country (2021-2032) Figure 49. Europe Biothrax (Anthrax Vaccine) Sales Share by Country (2021-2032) Figure 50. China Biothrax (Anthrax Vaccine) Revenue Share by Type (2021-2032) Figure 51. China Biothrax (Anthrax Vaccine) Sales Share by Type (2021-2032) Figure 52. China Biothrax (Anthrax Vaccine) Revenue Share by Application (2021-2032) Figure 53. China Biothrax (Anthrax Vaccine) Sales Share by Application (2021-2032) Figure 54. Asia Biothrax (Anthrax Vaccine) Revenue Share by Type (2021-2032) Figure 55. Asia Biothrax (Anthrax Vaccine) Sales Share by Type (2021-2032) Figure 56. Asia Biothrax (Anthrax Vaccine) Revenue Share by Application (2021-2032) Figure 57. Asia Biothrax (Anthrax Vaccine) Sales Share by Application (2021-2032) Figure 58. Asia Biothrax (Anthrax Vaccine) Revenue Share by Country (2021-2032) Figure 59. Asia Biothrax (Anthrax Vaccine) Sales Share by Country (2021-2032) Figure 60. SAMEA Biothrax (Anthrax Vaccine) Revenue Share by Type (2021-2032) Figure 61. SAMEA Biothrax (Anthrax Vaccine) Sales Share by Type (2021-2032) Figure 62. SAMEA Biothrax (Anthrax Vaccine) Revenue Share by Application (2021-2032) Figure 63. SAMEA Biothrax (Anthrax Vaccine) Sales Share by Application (2021-2032) Figure 64. SAMEA Biothrax (Anthrax Vaccine) Revenue Share by Country (2021-2032) Figure 65. SAMEA Biothrax (Anthrax Vaccine) Sales Share by Country (2021-2032) Figure 66. Biothrax (Anthrax Vaccine) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Biothrax (Anthrax Vaccine) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Cell Free PA Vaccines
Applications
  • Human Use
  • Animal Use
Companies covered
  • Merck
  • Tiankang
  • Zoetis
  • Vecol
  • Rosenbusch
  • Prondil
  • PharmAthene
  • Merial
  • JOVAC
  • IVPM
  • Intervac
  • Indian Immunologicals
  • CVCRI
  • Colorado Serum
  • Ceva Santé Animale
  • CDV
  • CAVAC
  • Botswana Vaccine Institute
  • Biogénesis-Bago
  • Bayer Sanidad Animal
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biothrax (Anthrax Vaccine) Market by Type
  3. 1.2.1 Global Biothrax (Anthrax Vaccine) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Live Vaccines
  5. 1.2.3 Cell Free PA Vaccines
  6. 1.3 Biothrax (Anthrax Vaccine) Market by Application
  7. 1.3.1 Global Biothrax (Anthrax Vaccine) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Human Use
  9. 1.3.3 Animal Use
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Biothrax (Anthrax Vaccine) Market Dynamics
  1. 2.1 Biothrax (Anthrax Vaccine) Industry Trends
  2. 2.2 Biothrax (Anthrax Vaccine) Industry Drivers
  3. 2.3 Biothrax (Anthrax Vaccine) Industry Opportunities and Challenges
  4. 2.4 Biothrax (Anthrax Vaccine) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Biothrax (Anthrax Vaccine) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Biothrax (Anthrax Vaccine) Revenue by Region
  3. 3.2.1 Global Biothrax (Anthrax Vaccine) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biothrax (Anthrax Vaccine) Revenue by Region (2021-2026)
  5. 3.2.3 Global Biothrax (Anthrax Vaccine) Revenue by Region (2027-2032)
  6. 3.2.4 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Biothrax (Anthrax Vaccine) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Biothrax (Anthrax Vaccine) Sales by Region
  9. 3.4.1 Global Biothrax (Anthrax Vaccine) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Biothrax (Anthrax Vaccine) Sales by Region (2021-2026)
  11. 3.4.3 Global Biothrax (Anthrax Vaccine) Sales by Region (2027-2032)
  12. 3.4.4 Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Biothrax (Anthrax Vaccine) Revenue by Manufacturers
  2. 4.1.1 Global Biothrax (Anthrax Vaccine) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Biothrax (Anthrax Vaccine) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biothrax (Anthrax Vaccine) Sales by Manufacturers
  6. 4.2.1 Global Biothrax (Anthrax Vaccine) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Biothrax (Anthrax Vaccine) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Biothrax (Anthrax Vaccine) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Biothrax (Anthrax Vaccine) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Biothrax (Anthrax Vaccine) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Biothrax (Anthrax Vaccine) Manufacturers, Product Type & Application
  13. 4.7 Global Biothrax (Anthrax Vaccine) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Biothrax (Anthrax Vaccine) Market CR5 and HHI
  16. 4.8.2 2025 Biothrax (Anthrax Vaccine) Tier 1, Tier 2, and Tier 3
5 Biothrax (Anthrax Vaccine) Market by Type
  1. 5.1 Global Biothrax (Anthrax Vaccine) Revenue by Type
  2. 5.1.1 Global Biothrax (Anthrax Vaccine) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Biothrax (Anthrax Vaccine) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Biothrax (Anthrax Vaccine) Sales by Type
  6. 5.2.1 Global Biothrax (Anthrax Vaccine) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biothrax (Anthrax Vaccine) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Biothrax (Anthrax Vaccine) Price by Type
6 Biothrax (Anthrax Vaccine) Market by Application
  1. 6.1 Global Biothrax (Anthrax Vaccine) Revenue by Application
  2. 6.1.1 Global Biothrax (Anthrax Vaccine) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Biothrax (Anthrax Vaccine) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Biothrax (Anthrax Vaccine) Sales by Application
  6. 6.2.1 Global Biothrax (Anthrax Vaccine) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Biothrax (Anthrax Vaccine) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Biothrax (Anthrax Vaccine) Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Biothrax (Anthrax Vaccine) Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Tiankang
  8. 7.2.1 Tiankang Company Information
  9. 7.2.2 Tiankang Business Overview
  10. 7.2.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Tiankang Biothrax (Anthrax Vaccine) Product Portfolio
  12. 7.2.5 Tiankang Recent Developments
  13. 7.3 Zoetis
  14. 7.3.1 Zoetis Company Information
  15. 7.3.2 Zoetis Business Overview
  16. 7.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zoetis Biothrax (Anthrax Vaccine) Product Portfolio
  18. 7.3.5 Zoetis Recent Developments
  19. 7.4 Vecol
  20. 7.4.1 Vecol Company Information
  21. 7.4.2 Vecol Business Overview
  22. 7.4.3 Vecol Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Vecol Biothrax (Anthrax Vaccine) Product Portfolio
  24. 7.4.5 Vecol Recent Developments
  25. 7.5 Rosenbusch
  26. 7.5.1 Rosenbusch Company Information
  27. 7.5.2 Rosenbusch Business Overview
  28. 7.5.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolio
  30. 7.5.5 Rosenbusch Recent Developments
  31. 7.6 Prondil
  32. 7.6.1 Prondil Company Information
  33. 7.6.2 Prondil Business Overview
  34. 7.6.3 Prondil Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Prondil Biothrax (Anthrax Vaccine) Product Portfolio
  36. 7.6.5 Prondil Recent Developments
  37. 7.7 PharmAthene
  38. 7.7.1 PharmAthene Company Information
  39. 7.7.2 PharmAthene Business Overview
  40. 7.7.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 PharmAthene Biothrax (Anthrax Vaccine) Product Portfolio
  42. 7.7.5 PharmAthene Recent Developments
  43. 7.8 Merial
  44. 7.8.1 Merial Company Information
  45. 7.8.2 Merial Business Overview
  46. 7.8.3 Merial Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Merial Biothrax (Anthrax Vaccine) Product Portfolio
  48. 7.8.5 Merial Recent Developments
  49. 7.9 JOVAC
  50. 7.9.1 JOVAC Company Information
  51. 7.9.2 JOVAC Business Overview
  52. 7.9.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 JOVAC Biothrax (Anthrax Vaccine) Product Portfolio
  54. 7.9.5 JOVAC Recent Developments
  55. 7.10 IVPM
  56. 7.10.1 IVPM Company Information
  57. 7.10.2 IVPM Business Overview
  58. 7.10.3 IVPM Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 IVPM Biothrax (Anthrax Vaccine) Product Portfolio
  60. 7.10.5 IVPM Recent Developments
  61. 7.11 Intervac
  62. 7.11.1 Intervac Company Information
  63. 7.11.2 Intervac Business Overview
  64. 7.11.3 Intervac Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Intervac Biothrax (Anthrax Vaccine) Product Portfolio
  66. 7.11.5 Intervac Recent Developments
  67. 7.12 Indian Immunologicals
  68. 7.12.1 Indian Immunologicals Company Information
  69. 7.12.2 Indian Immunologicals Business Overview
  70. 7.12.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolio
  72. 7.12.5 Indian Immunologicals Recent Developments
  73. 7.13 CVCRI
  74. 7.13.1 CVCRI Company Information
  75. 7.13.2 CVCRI Business Overview
  76. 7.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 CVCRI Biothrax (Anthrax Vaccine) Product Portfolio
  78. 7.13.5 CVCRI Recent Developments
  79. 7.14 Colorado Serum
  80. 7.14.1 Colorado Serum Company Information
  81. 7.14.2 Colorado Serum Business Overview
  82. 7.14.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolio
  84. 7.14.5 Colorado Serum Recent Developments
  85. 7.15 Ceva Santé Animale
  86. 7.15.1 Ceva Santé Animale Company Information
  87. 7.15.2 Ceva Santé Animale Business Overview
  88. 7.15.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Portfolio
  90. 7.15.5 Ceva Santé Animale Recent Developments
  91. 7.16 CDV
  92. 7.16.1 CDV Company Information
  93. 7.16.2 CDV Business Overview
  94. 7.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 CDV Biothrax (Anthrax Vaccine) Product Portfolio
  96. 7.16.5 CDV Recent Developments
  97. 7.17 CAVAC
  98. 7.17.1 CAVAC Company Information
  99. 7.17.2 CAVAC Business Overview
  100. 7.17.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 CAVAC Biothrax (Anthrax Vaccine) Product Portfolio
  102. 7.17.5 CAVAC Recent Developments
  103. 7.18 Botswana Vaccine Institute
  104. 7.18.1 Botswana Vaccine Institute Company Information
  105. 7.18.2 Botswana Vaccine Institute Business Overview
  106. 7.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolio
  108. 7.18.5 Botswana Vaccine Institute Recent Developments
  109. 7.19 Biogénesis-Bago
  110. 7.19.1 Biogénesis-Bago Company Information
  111. 7.19.2 Biogénesis-Bago Business Overview
  112. 7.19.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Portfolio
  114. 7.19.5 Biogénesis-Bago Recent Developments
  115. 7.20 Bayer Sanidad Animal
  116. 7.20.1 Bayer Sanidad Animal Company Information
  117. 7.20.2 Bayer Sanidad Animal Business Overview
  118. 7.20.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolio
  120. 7.20.5 Bayer Sanidad Animal Recent Developments
  121. 7.21 Agrovet
  122. 7.21.1 Agrovet Company Information
  123. 7.21.2 Agrovet Business Overview
  124. 7.21.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Agrovet Biothrax (Anthrax Vaccine) Product Portfolio
  126. 7.21.5 Agrovet Recent Developments
8 North America
  1. 8.1 North America Biothrax (Anthrax Vaccine) Market Size by Type
  2. 8.1.1 North America Biothrax (Anthrax Vaccine) Revenue by Type (2021-2032)
  3. 8.1.2 North America Biothrax (Anthrax Vaccine) Sales by Type (2021-2032)
  4. 8.1.3 North America Biothrax (Anthrax Vaccine) Price by Type (2021-2032)
  5. 8.2 North America Biothrax (Anthrax Vaccine) Market Size by Application
  6. 8.2.1 North America Biothrax (Anthrax Vaccine) Revenue by Application (2021-2032)
  7. 8.2.2 North America Biothrax (Anthrax Vaccine) Sales by Application (2021-2032)
  8. 8.2.3 North America Biothrax (Anthrax Vaccine) Price by Application (2021-2032)
  9. 8.3 North America Biothrax (Anthrax Vaccine) Market Size by Country
  10. 8.3.1 North America Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Biothrax (Anthrax Vaccine) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Biothrax (Anthrax Vaccine) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Biothrax (Anthrax Vaccine) Market Size by Type
  2. 9.1.1 Europe Biothrax (Anthrax Vaccine) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Biothrax (Anthrax Vaccine) Sales by Type (2021-2032)
  4. 9.1.3 Europe Biothrax (Anthrax Vaccine) Price by Type (2021-2032)
  5. 9.2 Europe Biothrax (Anthrax Vaccine) Market Size by Application
  6. 9.2.1 Europe Biothrax (Anthrax Vaccine) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Biothrax (Anthrax Vaccine) Sales by Application (2021-2032)
  8. 9.2.3 Europe Biothrax (Anthrax Vaccine) Price by Application (2021-2032)
  9. 9.3 Europe Biothrax (Anthrax Vaccine) Market Size by Country
  10. 9.3.1 Europe Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Biothrax (Anthrax Vaccine) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Biothrax (Anthrax Vaccine) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Biothrax (Anthrax Vaccine) Market Size by Type
  2. 10.1.1 China Biothrax (Anthrax Vaccine) Revenue by Type (2021-2032)
  3. 10.1.2 China Biothrax (Anthrax Vaccine) Sales by Type (2021-2032)
  4. 10.1.3 China Biothrax (Anthrax Vaccine) Price by Type (2021-2032)
  5. 10.2 China Biothrax (Anthrax Vaccine) Market Size by Application
  6. 10.2.1 China Biothrax (Anthrax Vaccine) Revenue by Application (2021-2032)
  7. 10.2.2 China Biothrax (Anthrax Vaccine) Sales by Application (2021-2032)
  8. 10.2.3 China Biothrax (Anthrax Vaccine) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biothrax (Anthrax Vaccine) Market Size by Type
  2. 11.1.1 Asia Biothrax (Anthrax Vaccine) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Biothrax (Anthrax Vaccine) Sales by Type (2021-2032)
  4. 11.1.3 Asia Biothrax (Anthrax Vaccine) Price by Type (2021-2032)
  5. 11.2 Asia Biothrax (Anthrax Vaccine) Market Size by Application
  6. 11.2.1 Asia Biothrax (Anthrax Vaccine) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Biothrax (Anthrax Vaccine) Sales by Application (2021-2032)
  8. 11.2.3 Asia Biothrax (Anthrax Vaccine) Price by Application (2021-2032)
  9. 11.3 Asia Biothrax (Anthrax Vaccine) Market Size by Country
  10. 11.3.1 Asia Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Biothrax (Anthrax Vaccine) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Biothrax (Anthrax Vaccine) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biothrax (Anthrax Vaccine) Market Size by Type
  2. 12.1.1 SAMEA Biothrax (Anthrax Vaccine) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Biothrax (Anthrax Vaccine) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Biothrax (Anthrax Vaccine) Price by Type (2021-2032)
  5. 12.2 SAMEA Biothrax (Anthrax Vaccine) Market Size by Application
  6. 12.2.1 SAMEA Biothrax (Anthrax Vaccine) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Biothrax (Anthrax Vaccine) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Biothrax (Anthrax Vaccine) Price by Application (2021-2032)
  9. 12.3 SAMEA Biothrax (Anthrax Vaccine) Market Size by Country
  10. 12.3.1 SAMEA Biothrax (Anthrax Vaccine) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Biothrax (Anthrax Vaccine) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Biothrax (Anthrax Vaccine) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Biothrax (Anthrax Vaccine) Value Chain Analysis
  2. 13.1.1 Biothrax (Anthrax Vaccine) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Biothrax (Anthrax Vaccine) Production Mode & Process
  6. 13.2 Biothrax (Anthrax Vaccine) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Biothrax (Anthrax Vaccine) Distributors
  9. 13.2.3 Biothrax (Anthrax Vaccine) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst